Moreover, further research into the molecular mechanisms underlying this inhibition revealed that hnRNPK knockdown in lung cancer induced DNA damage and activated DDR, which in turn activated p53‐dependent inhibition of the progression of lung cancer. The gene discussed is HNRNPK; the disease is lung cancer.